TREOSULFAN FOR INJECTION DIN 02560585
Health Canada record
| Active ingredient(s) | TREOSULFAN 5 G |
|---|---|
| Dosage form | Powder |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AB02 TREOSULFAN |
| Original market date | 26-Nov-2025 |
| Current status date | 26-Nov-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TREOSULFAN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02517361 | TRECONDYV | MEDEXUS PHARMACEUTICALS INC. | Powder | TREOSULFAN 1 G | Approved |
| 02517388 | TRECONDYV | MEDEXUS PHARMACEUTICALS INC. | Powder | TREOSULFAN 5 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36076 | 2025-09-29 | Abbreviated New Drug Submission (ANDS) |
International API supply for TREOSULFAN
2 active FDA Drug Master Files.
Request a quote for TREOSULFAN FOR INJECTION